239 related articles for article (PubMed ID: 37490989)
1. Enhancing NKT cell-mediated immunity against hepatocellular carcinoma: Role of XYXD in promoting primary bile acid synthesis and improving gut microbiota.
Deng Z; Ouyang Z; Mei S; Zhang X; Li Q; Meng F; Hu Y; Dai X; Zhou S; Mao K; Huang C; Dai J; Yi C; Tan N; Feng T; Long H; Tian X
J Ethnopharmacol; 2024 Jan; 318(Pt B):116945. PubMed ID: 37490989
[TBL] [Abstract][Full Text] [Related]
2. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
[TBL] [Abstract][Full Text] [Related]
3. Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells.
Zhang D; Zhang L; Chen G; Xu Y; Yang H; Xiao Z; Chen J; Mu Y; Zhang H; Liu W; Liu P
Pharm Biol; 2020 Dec; 58(1):1229-1243. PubMed ID: 33332219
[TBL] [Abstract][Full Text] [Related]
4. Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma.
Shen R; Ke L; Li Q; Dang X; Shen S; Shen J; Li S; Liang L; Peng B; Kuang M; Ma Y; Yang Z; Hua Y
Hepatol Int; 2022 Apr; 16(2):396-411. PubMed ID: 35211843
[TBL] [Abstract][Full Text] [Related]
5. Xiayuxue Decoction ([symbols; see text]) attenuates hepatic stellate cell activation and sinusoidal endothelium defenestration in CCl4-induced fibrotic liver of mice.
Zhang LJ; Sun MY; Ning BB; Zhang WM; Chen GF; Mu YP; Zhang H; Liu J; Bian YQ; Liu P
Chin J Integr Med; 2014 Jul; 20(7):516-23. PubMed ID: 24972579
[TBL] [Abstract][Full Text] [Related]
6. Regulatory effect of Yinchenhao decoction on bile acid metabolism to improve the inflammatory microenvironment of hepatocellular carcinoma in mice.
Shi J; Zhu L; Tang BY; Yang WQ; Xi SY; Zhang CL; Li PF; Wang YJ; Guo KH; Huang JR; Huang CR; Yu ZX; Yu BK; Zhang CF; Zhang YM
J Nat Med; 2024 Jun; 78(3):633-643. PubMed ID: 38704807
[TBL] [Abstract][Full Text] [Related]
7. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract][Full Text] [Related]
8. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
[TBL] [Abstract][Full Text] [Related]
9. Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis.
Wei J; Ma L; Liu W; Wang Y; Shen C; Zhao X; Zhao C
J Ethnopharmacol; 2021 Aug; 276():114174. PubMed ID: 33932512
[TBL] [Abstract][Full Text] [Related]
10. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.
Li Q; Li M; Li F; Zhou W; Dang Y; Zhang L; Ji G
J Ethnopharmacol; 2020 Aug; 258():112896. PubMed ID: 32325178
[TBL] [Abstract][Full Text] [Related]
11. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
[TBL] [Abstract][Full Text] [Related]
12. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway.
Fu C; Zhang Y; Xi WJ; Xu K; Meng F; Ma T; Li W; Wu L; Chen Z
J Ethnopharmacol; 2023 May; 308():116191. PubMed ID: 36731809
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology].
Zou X; Sui Y; Tang XY; Zhang R; Shu Q; Gong T; Wu S; Sun ZW; Li WL; Qu ZY
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3597-3608. PubMed ID: 35850814
[TBL] [Abstract][Full Text] [Related]
14. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.
Yu J; Zhang H; Chen L; Ruan Y; Chen Y; Liu Q
Front Cell Infect Microbiol; 2021; 11():698852. PubMed ID: 34568090
[TBL] [Abstract][Full Text] [Related]
15. Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg/Th1 balance in hepatocellular carcinoma.
Wu L; Yang FR; Xing ML; Lu SF; Chen HL; Yang QW; Zhang YT; Lu Y; Huang Y
Phytomedicine; 2022 Jun; 100():154055. PubMed ID: 35344716
[TBL] [Abstract][Full Text] [Related]
16. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
[TBL] [Abstract][Full Text] [Related]
17. Effects of Xian-Ling-Gu-Bao capsule on the gut microbiota in ovariectomized rats: Metabolism and modulation.
Tang XY; Gao MX; Xiao HH; Dai ZQ; Yao ZH; Dai Y; Yao XS
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1176():122771. PubMed ID: 34058528
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS.
Bao Y; Wang S; Yang X; Li T; Xia Y; Meng X
J Ethnopharmacol; 2017 Feb; 198():468-478. PubMed ID: 28108381
[TBL] [Abstract][Full Text] [Related]
19. Xiayuxue decoction reduces renal injury by promoting macrophage apoptosis in hepatic cirrhotic rats.
Liu C; Cai J; Cheng Z; Dai X; Tao L; Zhang J; Xue D
Genet Mol Res; 2015 Sep; 14(3):10760-73. PubMed ID: 26400305
[TBL] [Abstract][Full Text] [Related]
20. Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC.
Sydor S; Best J; Messerschmidt I; Manka P; Vilchez-Vargas R; Brodesser S; Lucas C; Wegehaupt A; Wenning C; Aßmuth S; Hohenester S; Link A; Faber KN; Moshage H; Cubero FJ; Friedman SL; Gerken G; Trauner M; Canbay A; Bechmann LP
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00131. PubMed ID: 32352707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
